Investor Relations

NYSE: TDOC -0.30 -3.39%
Volume: 1,637,244
20 minute delay November 17, 2026

Teladoc Health is the global leader in virtual care.

We are transforming how better health happens.

Teladoc Health is delivering and orchestrating care across patients, care providers, platforms, and partners for more complete and personalized care. Through our technology, services and clinical expertise, we equip care teams to perform at their highest caliber and address comprehensive health needs – physical and mental, simple and complex, urgent and ongoing. By applying the power of technology and insights, we elevate care experiences and make moments of care more impactful. We work with health plans, employers, health systems, and partners around the world to unlock access and outcomes at unmatched scale, helping millions of people live their healthiest lives.

Investor Events

Investor News

November 17, 2026
Teladoc Health Expands Comprehensive Weight Care Program with Employer Contribution Option for GLP-1 Medications
New option gives employers greater flexibility to offer GLP-1 coverage and high-quality care that fits the needs of their workforce NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) - Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced an expansion of its Comprehensive Weight Care program that gives employers a new way to offer access to FDA-approved GLP-1 medications and comprehensive weight care while keeping medication spending predictable. Teladoc Health's Comprehensive Weight Care program now gives employers the option to contribute toward the cost of GLP-1 medications outside of traditional pharmacy benefit designs with flexible patient out of pocket costs. This offering enables employers to help employees and their families pay for authentic FDA-approved GLP-1 medications from Eli Lilly and Company and Novo, alongside comprehensive clinical care, nutrition and lifestyle support. This option comes as consumer demand for GLP-1s remains high and coverage remains...
Read More
November 3, 2026
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to three new employees. Effective November 1, 2026, in connection with the acquisition of Teledigm Health, LLC, three employees of Teledigm Health were granted awards of restricted stock units covering an aggregate of 40,768 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”). The restricted stock units vest, based on continued service to Teladoc Health, over three years. The awards were approved by the Compensation Committee of the Board of Directors of Teladoc Health and were granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as employment inducement awards pursuant to New York Stock Exchange Rule 303A.08. About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across...
Read More

Get in touch today

Contact Teladoc Health Investor Relations

Michael Minchak | Vice President, Investor Relations | IR@teladochealth.com